AC
RGEN icon

Allstate Corporation’s Repligen RGEN Stock Holding History

Allstate Corporation’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
+11,332
New +$1.58M 0.01% 697

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allstate Corporation's RGEN Position: Q1 2026 in Review

Allstate Corporation opened a new position in Repligen (RGEN) in Q1 2026: 11,332 shares worth $1.34M. The stake represents 0.01% of the portfolio and ranks #697 among its holdings.

441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Allstate Corporation held 11,332 shares of Repligen worth $1.34M as of Q1 2026.
  • Repligen was a new Allstate Corporation position in Q1 2026.
  • Repligen made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #697 holding.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.